A validated LC–MS/MS method for the rapid quantification of vilazodone in rat plasma: Application to a pharmacokinetic study

• We first reported a validated LC–MS/MS method for the quantification of vilazodone.
• The method was linear in the concentration range of 1.0 − 100 ng/mL.
• The method showed good sensitivity, reproducibility and fast analysis time.
• The method was applicable for rapid determination of vilazodone in rat plasma.

A rapid and sensitive LC–MS/MS method was developed for the quantification of vilazodone in rat plasma using escitalopram as internal standard. After extracted with organic solvent, post-treatment samples were chromatographed on an Agela C18 column. An isocratic mobile phase of acetonitrile: 5 mM ammonium acetate: formic acid (35:65:0.1, v/v/v) was applied at a flow rate of 0.25 mL/min. Detection was performed using multiple reaction-monitoring (MRM) modes at m/z 442.4 → 155.3 for vilazodone and m/z 325.1 → 109.0 for escitalopram. The method was linear in the concentration range of 1.0 − 100 ng/mL with a correlation coefficient ≥0.993. The intra- and inter-assay precision (%RSD) values were within 13.4%, and intra- and inter-day accuracy (%RE) ranged from −9.8 to 6.9%. The total analysis time was 2.2 min. The LC–MS/MS method was fully validated for its sensitivity, selectivity, stability, matrix effect and recovery. The data indicated that the developed method was rapid, specific and sensitive. This method was further and successfully applied in the pharmacokinetics study of vilazodone in rat.

Representative LC–MS/MS chromatogram of a blank plasma spiked with vilazodone (1.0 ng/mL, LLOQ) and escitalopram (IS).Figure optionsDownload as PowerPoint slide